Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
All patients expected to be recruited in H1 2022 Topline results anticipated in H2 2022 Gosselies, Belgium, 12 January 2020, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell...